Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
A winning horse: Why India’s top generics players are rushing to launch this blockbuster diabetes drug
Empagliflozin, which in addition to treating type-2 diabetes, also aids weight loss, and reduces cardiovascular and kidney ...
Diabetes drug price war heats up, making treatment more affordable
Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed SGLT2 inhibitor for type-2 diabetes ...
Common Diabetes Drug Price Slashed In India Due To Generic Versions
The price of commonly used diabetes drug empagliflozin has been slashed by almost one-tenth, with the entry of its generic ...
Good Morning America19h
Compound versions of some weight loss drugs to be restricted
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
Diabetes.co.uk20h
Retatrutide: How it Works, Evidence, Side Effects
Retatrutide mimics the effects of naturally occurring gut hormones to improve metabolic health. Stimulating insulin release ...
SurvivorNet on MSN22h
Can GLP-1 Drugs for Weight Loss Lower Cancer Risk? What Patients Need to Know About Obesity and Cancer
Because obesity and obesity-related conditions have been linked to several types of cancer, doctors believe that these ...
Popular weight loss drugs bring unexpected heart health benefits—researchers discuss implications
Weight loss drugs like Ozempic deliver more health benefits than expected.